Today's Hours: 10:00am - 6:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    editor, Waguih William IsHak.
    Contents:
    Introduction to Sexual Medicine
    The History of Modern Sexual Medicine
    Surveys of Sexual Behavior and Sexual Disorders
    The Human Sexual Response Cycle
    Facilitators and Barriers in Sexual History Taking
    Biopsychosocial Evaluation of Sexual Dysfunctions
    Biopsychosocial Treatment of Sexual Dysfunctions
    Evaluation of Male Hypoactive Sexual Desire Disorder
    Treatment of Male Hypoactive Sexual Desire Disorder
    Evaluation of Female Sexual Interest/Arousal Disorder
    Treatment of Female Sexual Interest/Arousal Disorder
    Evaluation of Erectile Disorder
    Treatment of Erectile Disorder
    Evaluation of Female Orgasmic Disorder
    Treatment of Female Orgasmic Disorder
    Evaluation of Delayed Ejaculation
    Treatment of Delayed Ejaculation
    Evaluation of Premature Ejaculation
    Treatment of Premature Ejaculation
    Evaluation of Genito-Pelvic Pain/Penetration Disorder
    Treatment of Genito-Pelvic Pain/Penetration Disorder
    Evaluation and Treatment of Sexual Disorders due to Medical Conditions
    Evaluation and Treatment of Substance/Medication-Induced Sexual Dysfunction
    Evaluation and Treatment of Hypersexual Disorder and Other Sexual Dysfunctions
    Myths About Sexual Health
    Sex and Pharmacological Sexual Enhancement
    Sex and Natural Sexual Enhancement: Sexual Techniques, Aphrodisiac Foods, and Nutraceuticals
    Sex and Sexual Orientation
    Sex and the Heart
    Sex and Cancer
    Sex and Chronic Physical Illness
    Sex and Chronic Psychiatric Illness
    Sexual Emergencies
    Sex and Quality of Life
    Alternative Medicine Approaches in Sexual Medicine
    Future Directions in Sexual Medicine.
    Digital Access Springer 2017
  • Article
    Moshal MG, Spitaels JM, Bhoola R.
    S Afr Med J. 1977 Oct 29;52(19):760-3.
    A total of 55 patients were treated with the histamine H2-receptor antagonist cimetidine (Tagamet: SKF) in an endoscopically controlled double-blind trial. Cimetide (200 or 300 mg every 6 hours) was administered to 36 patients, and placebo to 19 patients. Only patients who had been confirmed by endoscopy as having uncomplicated duodenal ulcers were admitted to the trial. Drug or placebo was administered in a randomized double-blind fashion for 6 weeks. Patients underwent clinical examination at weekly intervals. Haematological assessment was made weekly for 7 weeks, and biochemical variables were measured once a week or once every 2 weeks for 6 weeks. Endoscopy was repeated at 6 weeks unless the patient had to be excluded from the trial because of incessant pain after 14 days. No antacid or other treatment was allowed. Seventy-eight per cent of the patients became free of symptoms when treated with cimetidine, and 47% when treated with placebo (chi2 = 5,2235; P less than 0,025 in favour of cimetidine). Endoscopic evidence of healing revealed an improvement of 69,5% in those treated with cimetidine and one of 42% in those treated with placebo (chi2 = 3,8731; P less than 0,05 in favour of cimetidine). No haematological or biochemical changes were noted. It is concluded that the histamine H2-receptor antagonists have a definite place in the treatment of duodenal ulceration.
    Digital Access Access Options